Skip to content

The Chinese LUTS/BPH patients management project: a multicenter, prospective, real-world study

The Chinese LUTS/BPH patients management project: a multicenter, prospective, real-world study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200065445
Enrollment
Unknown
Registered
2022-11-04
Start date
2022-11-01
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

LUTS/BPH

Interventions

NA:NA

Sponsors

Zhejiang Provincial People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
45 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Male, aged 45-80 years (not including 80); 2. Clinical diagnosis of benign prostatic hyperplasia (BPH) with typical lower urinary tract symptoms (LUTS): frequent urination, dysuria, posturination dribbleb and/or incomplete urination, etc; 3. Including the first visit and treated patients, the doctor evaluated the need for at least one anti-BPH drug or surgical treatment; 4. Smart phone or tablet computer can be used for information filling; 5. Agree to sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Lower urinary tract symptoms due to urethral stricture, calculi, or space-occupying lesions; 2. Presence of known neurogenic or congenital lower urinary tract dysfunction, or anatomical abnormalities of the urinary tract, such as bladder or urethral diverticulum, ectopic ureteral orifice, etc.; 3. Presence of other serious diseases, such as malignant tumors, heart failure, uncontrolled hypertension, etc., which may affect the follow-up; 4. Estimated inability to cooperate with follow-up visits.

Design outcomes

Primary

MeasureTime frame
Changes in international prostate symptom score (IPSS) and Quality of Life (QoL) scores;

Secondary

MeasureTime frame
The incidence of BPH-related complications, including acute urinary retention, renal function injury, hematuria, urinary tract infection, bladder stones, etc.;The changes of maximum urinary flow rate (Qmax);The rate of BPH surgical treatment;Changes in pelvic pain isual Analogue Scale(VAS) score;

Countries

China

Contacts

Public ContactXu Zhihui

Zhejiang Provincial People's Hospital

jhtotal@163.com+86 13757179772

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026